Enlivex Therapeutics LtdNASDAQ:ENLV
- LAST PRICE1.7600
- TODAY'S CHANGE (%)0.0400 (2.3256%)
- Bid / Lots1.7100/ 10
- Ask / Lots1.8900/ 1
- Open / Previous Close1.7600 / 1.7200
- Day Range
- 52 Week Range
- Volume17,425
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ENLV |
|---|---|---|
| 09:32 ET | 1490 | 1.76 |
| 09:42 ET | 200 | 1.76 |
| 09:46 ET | 2700 | 1.7796 |
| 10:18 ET | 3374 | 1.78 |
| 10:26 ET | 1100 | 1.79 |
| 10:29 ET | 100 | 1.78 |
| 10:31 ET | 350 | 1.8175 |
| 10:33 ET | 100 | 1.8 |
| 10:38 ET | 200 | 1.79 |
| 10:42 ET | 100 | 1.78 |
| 10:44 ET | 100 | 1.78 |
| 10:45 ET | 100 | 1.78 |
| 10:47 ET | 100 | 1.78 |
| 10:51 ET | 100 | 1.78 |
| 10:54 ET | 200 | 1.78 |
| 10:56 ET | 100 | 1.78 |
| 11:00 ET | 100 | 1.78 |
| 11:02 ET | 100 | 1.78 |
| 11:03 ET | 100 | 1.78 |
| 11:07 ET | 200 | 1.825 |
| 11:09 ET | 100 | 1.78 |
| 11:12 ET | 100 | 1.78 |
| 11:16 ET | 100 | 1.78 |
| 11:18 ET | 100 | 1.78 |
| 11:48 ET | 100 | 1.85 |
| 12:06 ET | 100 | 1.77 |
| 12:21 ET | 900 | 1.76 |
| 01:02 ET | 918 | 1.78 |
| 01:08 ET | 200 | 1.78 |
| 01:24 ET | 100 | 1.78 |
| 02:02 ET | 533 | 1.78 |
| 02:03 ET | 100 | 1.785 |
| 02:07 ET | 100 | 1.785 |
| 02:23 ET | 100 | 1.78 |
| 02:25 ET | 100 | 1.78 |
| 02:34 ET | 1000 | 1.7638 |
| 02:52 ET | 100 | 1.76 |
Nov 21, 2023
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer, from 7:00AM ET on Tuesday Nov 21, 2023 by Dow Jones
7:00AM ET on Tuesday Nov 21, 2023 by Dow Jones
Nov 6, 2023
Thinking about buying stock in Aldeyra Therapeutics, Alphabet Inc., DraftKings, Evelo Biosciences, or Enlivex Therapeutics?, from 9:31AM ET on Monday Nov 06, 2023 by Dow Jones
9:31AM ET on Monday Nov 06, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Enlivex Therapeutics Ltd | 32.0M | -1.1x | --- |
Rezolute Inc | 31.9M | -0.8x | --- |
Eledon Pharmaceuticals Inc | 32.2M | -0.2x | --- |
CytoMed Therapeutics Ltd | 42.0M | -9.0x | --- |
Neoleukin Therapeutics Inc | 32.8M | -0.2x | --- |
Achilles Therapeutics PLC | 33.8M | -0.4x | --- |
Company Information
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
Contact Information
- Headquarters
- 14 Einstein St.NESS-ZIONA, Israel 7403618
- Phone
- ---
- Fax
- ---
Executives
- Chief Executive Officer
- Oren Hershkovitz
- Executive Chairman of the Board
- Shai Novik
- Founder, Chief Scientific Officer and Medical Officer
- Dror Mevorach
- Chief Financial Officer
- Shachar Shlosberger
- Director
- Baruch Halpert
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.06 |
EPS | $-1.63 |
Book Value | $3.09 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
